Vorapaxar acts by inhibiting: (A) GPIIa / IIIb, (B) P2Y12 receptor, (C) PAR - 1, (D) Antithrombin - 3
Answer is C. Vorapaxar inhibits Protease Activated Receptor 1 (PAR1) which is a thrombin receptor and thus can be used as a antiplatelet drug in M.I